Covered recipient · General Payments record
TERRI DENISE BUCHANAN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,880.93
- Reported across 163 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $937.49 | 55 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $410.13 | 23 |
| ABBVIE INC. | $290.56 | 20 |
| PFIZER INC. | $46.26 | 3 |
| IRONSHORE PHARMACEUTICALS INC. | $43.71 | 2 |
| Radius Health, Inc. | $34.22 | 1 |
| Acerta Pharma LLC | $28.48 | 2 |
| Amgen Inc. | $24.23 | 1 |
| Verrica Pharmaceuticals Inc. | $22.12 | 1 |
| TOLMAR, INC. | $21.00 | 1 |
| UCB, Inc. | $16.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.33 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842428 | CMS |
| ABBVIE INC. | $12.00 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842430 | CMS |
| ABBVIE INC. | $25.88 | 01/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842432 | CMS |
| ABBVIE INC. | $7.70 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842434 | CMS |
| ABBVIE INC. | $15.70 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842436 | CMS |
| ABBVIE INC. | $19.60 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842438 | CMS |
| ABBVIE INC. | $17.95 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842440 | CMS |
| ABBVIE INC. | $8.02 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842442 | CMS |
| ABBVIE INC. | $6.01 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842444 | CMS |
| ABBVIE INC. | $27.36 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842446 | CMS |
| ABBVIE INC. | $5.28 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842448 | CMS |
| ABBVIE INC. | $23.35 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842450 | CMS |
| ABBVIE INC. | $3.57 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842452 | CMS |
| ABBVIE INC. | $19.03 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842454 | CMS |
| ABBVIE INC. | $8.27 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842456 | CMS |
| ABBVIE INC. | $26.99 | 09/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842458 | CMS |
| ABBVIE INC. | $8.27 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842460 | CMS |
| ABBVIE INC. | $10.64 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842462 | CMS |
| ABBVIE INC. | $22.73 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842464 | CMS |
| ABBVIE INC. | $14.88 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106842466 | CMS |
| Amgen Inc. | $24.23 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117516293 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.27 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105450103 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.21 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105229385 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $19.76 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146310783 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $23.95 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146257199 | CMS |
| Novo Nordisk Inc | $11.38 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100446703 | CMS |
| Novo Nordisk Inc | $18.86 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100567538 | CMS |
| Novo Nordisk Inc | $18.19 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100545542 | CMS |
| Novo Nordisk Inc | $8.46 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100396752 | CMS |
| Novo Nordisk Inc | $19.14 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100520031 | CMS |
| Novo Nordisk Inc | $14.57 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100574960 | CMS |
| Novo Nordisk Inc | $16.66 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100271774 | CMS |
| Novo Nordisk Inc | $9.14 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100475377 | CMS |
| Novo Nordisk Inc | $16.80 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100496811 | CMS |
| Novo Nordisk Inc | $18.70 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100348302 | CMS |
| Novo Nordisk Inc | $21.15 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100257184 | CMS |
| Novo Nordisk Inc | $18.48 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100350832 | CMS |
| Novo Nordisk Inc | $15.38 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100493783 | CMS |
| Novo Nordisk Inc | $18.46 | 08/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100310365 | CMS |
| Novo Nordisk Inc | $23.53 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100537708 | CMS |
| Novo Nordisk Inc | $22.54 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100494207 | CMS |
| Novo Nordisk Inc | $17.73 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100432773 | CMS |
| Novo Nordisk Inc | $13.23 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100638106 | CMS |
| Novo Nordisk Inc | $20.24 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100640846 | CMS |
| Novo Nordisk Inc | $18.23 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100615405 | CMS |
| Novo Nordisk Inc | $28.60 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100321162 | CMS |
| Novo Nordisk Inc | $19.85 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100474636 | CMS |
| Novo Nordisk Inc | $20.81 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100292320 | CMS |
| PFIZER INC. | $17.83 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131394192 | CMS |
| PFIZER INC. | $13.26 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131884151 | CMS |
| PFIZER INC. | $15.17 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131979654 | CMS |
| Radius Health, Inc. | $34.22 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090043326 | CMS |
| Tolmar, Inc. | $21.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138721478 | CMS |
| UCB, Inc. | $16.78 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143428950 | CMS |
| Verrica Pharmaceuticals Inc. | $22.12 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118389828 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.